FDA Inspection 1079804 — Chartwell Pharmaceuticals Amityville, LLC

Chartwell Pharmaceuticals Amityville, LLC — FEI 2433247

The FDA completed an inspection of Chartwell Pharmaceuticals Amityville, LLC on February 13, 2019 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 13, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Amityville, NY (United States)

Citations

IDCFRDescription
122721 CFR 211.67(c)Cleaning/maintenance records not kept
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
191221 CFR 211.166(a)Written program not followed
431621 CFR 211.84(d)(3)Testing Containers & Closures Conformity with Specs